Watch Ticker

Acrivon Therapeutics, Inc. Common Stock

Go to Acrivon Therapeutics, Inc. Common Stock Website

$1.33

0.07 (5.56%)

Live

Previous Close

$1.26

Day Range

$1.25 - $1.33

Previous Day Range

$1.21 - $1.2882

Market Cap

$39.5 million USD

Day Vol.

120100

Previous Day Vol.

141152

Currency

USD

Primary Exchange

Nasdaq

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient resp...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight

A comprehensive report reveals over 50 companies are developing 55+ pipeline drugs for endometrial cancer, focusing on advanced therapies and improving treatment paradigms for postmenopausal women.

Related tickers: DSNKY, ACRV, ESAIY.

Read Full Article

N/A - Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis

Acrivon Therapeutics reported positive data from its ongoing Phase 2 study of ACR-368 in endometrial cancer, with a confirmed overall response rate of 62.5% in OncoSignature-positive patients. The company also disclosed the IND clearance and activation of initial clinical sites for its next candidate, ACR-2316, ahead of schedule.

Related tickers: ACRV.

Read Full Article

Trending Tickers

Please sign in to view